
Jeanette M. Lieb
Examiner (ID: 4527, Phone: (571)270-3490 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1675, 1654 |
| Total Applications | 1052 |
| Issued Applications | 767 |
| Pending Applications | 108 |
| Abandoned Applications | 207 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18844488
[patent_doc_number] => 20230406892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => BACTERIOCINS FOR CONTROL OF SALMONELLA ENTERICA
[patent_app_type] => utility
[patent_app_number] => 17/761854
[patent_app_country] => US
[patent_app_date] => 2020-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39510
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761854
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/761854 | BACTERIOCINS FOR CONTROL OF SALMONELLA ENTERICA | Sep 20, 2020 | Pending |
Array
(
[id] => 16805854
[patent_doc_number] => 20210128407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => PROPOFOL FORMULATIONS WITH NON-REACTIVE CONTAINER CLOSURES
[patent_app_type] => utility
[patent_app_number] => 16/948316
[patent_app_country] => US
[patent_app_date] => 2020-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13689
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16948316
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/948316 | PROPOFOL FORMULATIONS WITH NON-REACTIVE CONTAINER CLOSURES | Sep 12, 2020 | Abandoned |
Array
(
[id] => 16680754
[patent_doc_number] => 10940210
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-09
[patent_title] => BSH complex for boron neutron capture therapy
[patent_app_type] => utility
[patent_app_number] => 17/017171
[patent_app_country] => US
[patent_app_date] => 2020-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 7748
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17017171
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/017171 | BSH complex for boron neutron capture therapy | Sep 9, 2020 | Issued |
Array
(
[id] => 17982584
[patent_doc_number] => 20220348620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => Engineered Peptide and Peptide Mimetic Compositions and Methods
[patent_app_type] => utility
[patent_app_number] => 17/641346
[patent_app_country] => US
[patent_app_date] => 2020-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28420
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17641346
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/641346 | Engineered peptide and peptide mimetic compositions and methods | Sep 8, 2020 | Issued |
Array
(
[id] => 17392485
[patent_doc_number] => 11241473
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-08
[patent_title] => Bicyclic peptide ligands and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/010438
[patent_app_country] => US
[patent_app_date] => 2020-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25229
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 228
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17010438
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/010438 | Bicyclic peptide ligands and uses thereof | Sep 1, 2020 | Issued |
Array
(
[id] => 16776578
[patent_doc_number] => 20210113655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => POLYPEPTIDE-POLYMER CONJUGATES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/009472
[patent_app_country] => US
[patent_app_date] => 2020-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13724
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17009472
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/009472 | Polypeptide-polymer conjugates and methods of use thereof | Aug 31, 2020 | Issued |
Array
(
[id] => 17895475
[patent_doc_number] => 20220305137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => DRUG CONTAINING TARGETING LIPOSOMES
[patent_app_type] => utility
[patent_app_number] => 17/638988
[patent_app_country] => US
[patent_app_date] => 2020-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638988
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/638988 | DRUG CONTAINING TARGETING LIPOSOMES | Aug 30, 2020 | Pending |
Array
(
[id] => 17851897
[patent_doc_number] => 20220281939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => MODIFIED TFF2 POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 17/638761
[patent_app_country] => US
[patent_app_date] => 2020-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20215
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638761
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/638761 | MODIFIED TFF2 POLYPEPTIDES | Aug 26, 2020 | Pending |
Array
(
[id] => 17082053
[patent_doc_number] => 20210277059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => STABILIZED MINIMAL COILED-COIL MIMETICS
[patent_app_type] => utility
[patent_app_number] => 17/003686
[patent_app_country] => US
[patent_app_date] => 2020-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17003686
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/003686 | Stabilized minimal coiled-coil mimetics | Aug 25, 2020 | Issued |
Array
(
[id] => 20644722
[patent_doc_number] => 12599647
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-14
[patent_title] => Peptide amide composition and preparation method therefor
[patent_app_type] => utility
[patent_app_number] => 17/637189
[patent_app_country] => US
[patent_app_date] => 2020-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 12316
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 798
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17637189
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/637189 | Peptide amide composition and preparation method therefor | Aug 23, 2020 | Issued |
Array
(
[id] => 16506185
[patent_doc_number] => 20200385441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => IMMUNOTHERAPEUTIC COMPOSITION FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/997963
[patent_app_country] => US
[patent_app_date] => 2020-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31204
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16997963
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/997963 | IMMUNOTHERAPEUTIC COMPOSITION FOR THE TREATMENT OF CANCER | Aug 19, 2020 | Abandoned |
Array
(
[id] => 18537479
[patent_doc_number] => 20230242572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => a-CARBONYL ALKENYL ESTER PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/801514
[patent_app_country] => US
[patent_app_date] => 2020-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18043
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17801514
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/801514 | a-CARBONYL ALKENYL ESTER PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Aug 18, 2020 | Pending |
Array
(
[id] => 17890746
[patent_doc_number] => 11453699
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-27
[patent_title] => Antimicrobial compounds and/or modulators of microbial infections and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 16/996473
[patent_app_country] => US
[patent_app_date] => 2020-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 53
[patent_no_of_words] => 13244
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16996473
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/996473 | Antimicrobial compounds and/or modulators of microbial infections and methods of using the same | Aug 17, 2020 | Issued |
Array
(
[id] => 17769371
[patent_doc_number] => 11401298
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-02
[patent_title] => Means and methods for site-specific functionalization of polypeptides
[patent_app_type] => utility
[patent_app_number] => 16/993877
[patent_app_country] => US
[patent_app_date] => 2020-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 28
[patent_no_of_words] => 26307
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16993877
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/993877 | Means and methods for site-specific functionalization of polypeptides | Aug 13, 2020 | Issued |
Array
(
[id] => 16555777
[patent_doc_number] => 20210000925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => CLOTTING COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/984543
[patent_app_country] => US
[patent_app_date] => 2020-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16984543
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/984543 | Clotting composition | Aug 3, 2020 | Issued |
Array
(
[id] => 16452563
[patent_doc_number] => 20200361989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => COMPOSITION FOR AUTOPHAGY INHIBITING IN CELL, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEOPLASTIC DISEASE OR INHIBITING ANTI-CANCER AGENTS RESISTANCE CONTAINING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/945382
[patent_app_country] => US
[patent_app_date] => 2020-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5441
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16945382
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/945382 | COMPOSITION FOR AUTOPHAGY INHIBITING IN CELL, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEOPLASTIC DISEASE OR INHIBITING ANTI-CANCER AGENTS RESISTANCE CONTAINING THE SAME | Jul 30, 2020 | Abandoned |
Array
(
[id] => 20479301
[patent_doc_number] => 12527764
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-20
[patent_title] => Methods and compositions for treating androgen receptor deficient, androgen receptor low, and castration-resistant prostate cancers
[patent_app_type] => utility
[patent_app_number] => 17/629333
[patent_app_country] => US
[patent_app_date] => 2020-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 57
[patent_figures_cnt] => 105
[patent_no_of_words] => 11631
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17629333
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/629333 | Methods and compositions for treating androgen receptor deficient, androgen receptor low, and castration-resistant prostate cancers | Jul 22, 2020 | Issued |
Array
(
[id] => 17958610
[patent_doc_number] => 20220339190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => COMPOSITIONS FOR TREATMENT OF INFERTILITY CAUSED BY POOR SEMEN QUALITY, METHODS FOR PREPARING THE SAME AND APPLICATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/626574
[patent_app_country] => US
[patent_app_date] => 2020-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19141
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17626574
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/626574 | COMPOSITIONS FOR TREATMENT OF INFERTILITY CAUSED BY POOR SEMEN QUALITY, METHODS FOR PREPARING THE SAME AND APPLICATIONS THEREOF | Jul 12, 2020 | Abandoned |
Array
(
[id] => 19975927
[patent_doc_number] => 12343383
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-01
[patent_title] => High concentration insulin formulation
[patent_app_type] => utility
[patent_app_number] => 17/626025
[patent_app_country] => US
[patent_app_date] => 2020-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 2355
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17626025
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/626025 | High concentration insulin formulation | Jul 9, 2020 | Issued |
Array
(
[id] => 16466790
[patent_doc_number] => 20200368327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => METHODS FOR PREPARING MODIFIED VON WILLEBRAND FACTOR
[patent_app_type] => utility
[patent_app_number] => 16/925411
[patent_app_country] => US
[patent_app_date] => 2020-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22997
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16925411
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/925411 | Methods for preparing modified von Willebrand factor | Jul 9, 2020 | Issued |